PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Sinopharm Group Co's PE Ratio without NRI is 5.41. Sinopharm Group Co's 5-Year EBITDA growth rate is 10.70%. Therefore, Sinopharm Group Co's PEG Ratio for today is 0.51.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Sinopharm Group Co's PEG Ratio or its related term are showing as below:
SHTDF'
s PEG Ratio Range Over the Past 10 Years
Min: 0.47 Med: 0.58 Max: 0.68
Current: 0.51
During the past 13 years, Sinopharm Group Co's highest PEG Ratio was 0.68. The lowest was 0.47. And the median was 0.58.
SHTDF's PEG Ratio is ranked better than 73.33% of 45
companies
in the Medical Distribution industry
Industry Median: 1.04
vs SHTDF: 0.51
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Sinopharm Group Co PEG Ratio Historical Data
The historical data trend for Sinopharm Group Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sinopharm Group Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co PEG Ratio Distribution
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's PEG Ratio falls into.
Sinopharm Group Co PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
Sinopharm Group Co's PEG Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Sinopharm Group Co (OTCPK:SHTDF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Sinopharm Group Co PEG Ratio Related Terms
Thank you for viewing the detailed overview of Sinopharm Group Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Sinopharm Group Co (Sinopharm Group Co) Business Description
Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHTDF has been successfully added to your 